/KERN

KERN Stock - Akerna Corp.

Q: What is the analyst price target for KERN?

Analyst price target information is not currently available for KERN.

Q: What is KERN's market cap?

Market capitalization information is not currently available for KERN.

Healthcare|Medical - Healthcare Information Services|NASDAQ

$0.31+36.94%

+$0.08 (+36.94%) • Feb 8

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.34

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for KERN

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2018

FY2019

FY2021

FY2022

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta2.79

52W High$20.40

52W Low$0.25

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2022	FY2021	FY2019	FY2018
Revenue	$20.54M	$13.65M	$20.68M	$10.92M	N/A
Gross Profit	$4.72M	$8.23M	$12.57M	$6.29M	N/A
Gross Margin	23.0%	60.3%	60.7%	57.6%	N/A
Operating Income	$-17,747,000	$-16,478,384	$-18,972,009	$-12,415,678	$-906,166
Net Income	$-21,300,000	$-58,625,436	$-33,571,633	$-12,306,547	$-29,957
Net Margin	-103.7%	-429.6%	-162.3%	-112.7%	N/A
EPS	$-0.51	$-20.02	$-26.18	$-40.71	$-0.29

Company Overview

Akerna Corp. provides enterprise software solutions that enable regulatory compliance and inventory management in United States and Canada. The company offers MJ Platform for the cannabis, hemp, and CBD industry; and Leaf Data Systems, a government regulatory software. It also provides consulting services to cannabis industry; business intelligence, data analytics and other software related services; and Last Call Analytics, a tool for alcohol brands to analyze their retail sales analytics. In addition, the company operates seed-to-sale platform that offers tracking, reporting, and compliance tools to cannabis cultivators, processors, sellers, and clinics. Further, it provides cannabis cultivation management and compliance software; and cannabis tracking technology that offers seed-to-sale-to-self data. Akerna Corp. was founded in 2010 and is headquartered in Denver, Colorado.

Visit Website

Earnings History & Surprises

KERN

Beat Rate

17%

Last 12 quarters

Avg Surprise

-23.0%

EPS vs Estimate

Beats / Misses

2/10

Last 12 quarters

Latest EPS

$-0.90

Q1 2024

EPS Surprise History

Q2 22

-17.6%

$-4.00vs$-3.40

Q3 22

-16.7%

$-2.80vs$-2.40

Q4 22

-13.3%

$-1.36vs$-1.20

Q1 23

-26.8%

$-0.90vs$-0.71

Q2 23

No data

Q3 23

-62.5%

$-0.52vs$-0.32

Q4 23

+51.2%

$-0.21vs$-0.43

Q1 24

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2024	May 13, 2024	—	—	—	—
Q1 2024	Mar 19, 2024	—	$-0.90	—	—
Q4 2023	Nov 14, 2023	$-0.43	$-0.21	+51.2%	✓ BEAT
Q3 2023	Aug 14, 2023	$-0.32	$-0.52	-62.5%	✗ MISS
Q2 2023	May 15, 2023	—	$-0.48	—	—
Q1 2023	Mar 21, 2023	$-0.71	$-0.90	-26.8%	✗ MISS
Q4 2022	Nov 14, 2022	$-1.20	$-1.36	-13.3%	✗ MISS
Q3 2022	Aug 10, 2022	$-2.40	$-2.80	-16.7%	✗ MISS
Q2 2022	May 9, 2022	$-3.40	$-4.00	-17.6%	✗ MISS
Q1 2022	Mar 21, 2022	$-2.80	$-3.20	-14.3%	✗ MISS
Q4 2021	Nov 8, 2021	$-3.40	$-1.20	+64.7%	✓ BEAT
Q3 2021	Aug 9, 2021	$-3.00	$-3.40	-13.3%	✗ MISS
Q2 2021	May 10, 2021	—	$-5.60	—	—
Q1 2021	Mar 22, 2021	$-4.20	$-5.80	-38.1%	✗ MISS
Q4 2020	Nov 12, 2020	—	$-6.80	—	—
Q3 2020	Sep 23, 2020	—	$-7.20	—	—
Q2 2020	May 12, 2020	$-4.00	$-8.60	-115.0%	✗ MISS
Q1 2020	Feb 12, 2020	$-4.60	$-8.00	-73.9%	✗ MISS
Q4 2019	Nov 14, 2019	—	$-5.20	—	—
Q1 2019	Mar 31, 2019	—	$0.79	—	—

Frequently Asked Questions about KERN

What is KERN's current stock price?

Akerna Corp. (KERN) is currently trading at $0.31 per share. The stock has moved +36.94% today.

What is the analyst price target for KERN?

No analyst price targets are currently available for this stock.

What sector is Akerna Corp. in?

Akerna Corp. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the NASDAQ exchange.

What is KERN's market cap?

Akerna Corp. has a market capitalization of $0.00 billion, making it a small-cap company.

Does KERN pay dividends?

No, Akerna Corp. does not currently pay a dividend to shareholders.